The Second Xiangya Hospital of Central South University — Changsha, Hunan

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Changsha →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of The Second Xiangya Hospital of Central South University, compiled from the ClinicalTrials.gov public registry.

472

Registered studies

199

Active

116

Recruiting now

161

Completed

32

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer (NSCLC) · Crohn's Disease · Chronic Lymphocytic Leukemia · Idiopathic Pulmonary Fibrosis

Recently updated registry entries

NCT06136559 — A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib… (Recruiting)
NCT03105102 — A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (Active Not Recruiting)
NCT06422143 — Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.